Product

Placebo Photodynamic therapy (PDT)

Aliases

Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)

1 clinical trial

1 indication

Indication

Superficial Basal Cell Carcinoma

Clinical trial

A Randomized, Double Blind, Vehicle-controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Status: Active (not recruiting), Estimated PCD: 2024-03-19